Cargando…
Impact of renal disease and comorbidities on mortality in hemodialysis patients with COVID-19: a multicenter experience from Germany
Autores principales: | Seidel, Maximilian, Hölzer, Bodo, Appel, Heiner, Babel, Nina, Westhoff, Timm H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429939/ https://www.ncbi.nlm.nih.gov/pubmed/32804355 http://dx.doi.org/10.1007/s40620-020-00828-8 |
Ejemplares similares
-
SARS-CoV-2–reactive cellular and humoral immunity in hemodialysis population
por: Anft, Moritz, et al.
Publicado: (2021) -
Association of hyperuricemia and serum uric acid lowering therapy with mortality in hemodialysis patients
por: Rohn, Benjamin, et al.
Publicado: (2020) -
Low‐density lipoprotein apheresis is associated with removal of SARS‐CoV‐2 antibodies
por: Bertram, Sebastian, et al.
Publicado: (2022) -
Predictors of impaired SARS-CoV-2 immunity in healthcare workers after vaccination with BNT162b2
por: Bertram, Sebastian, et al.
Publicado: (2022) -
Intensive blood pressure control is associated with improved patient and graft survival after renal transplantation
por: Pagonas, Nikolaos, et al.
Publicado: (2019)